Issue

Vol. 34 No. 6 (2022): Vol 34 Issue 6

Copyright (c) 2022 AJC

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Study of Antiviral Activity of Some Pyrimidine Ring Containing Compounds against COVID-19 Based on Molecular Docking and Quantum Chemical Calculations by DFT Method

https://doi.org/10.14233/ajchem.2022.23689
S. Helen
Department of Chemistry, Faculty of Science, Mawlana Bhashani Science and Technology University, Santosh, Tangail-1902, Bangladesh
M.A.K. Liton
Department of Chemistry, Faculty of Science, Mawlana Bhashani Science and Technology University, Santosh, Tangail-1902, Bangladesh
M. Das
Department of Chemistry, Faculty of Science, Mawlana Bhashani Science and Technology University, Santosh, Tangail-1902, Bangladesh
Md. Nuruzzaman
Department of Chemistry, Faculty of Science, Mawlana Bhashani Science and Technology University, Santosh, Tangail-1902, Bangladesh

Corresponding Author(s) : M.A.K. Liton

aklitonchemmbstu@gmail.com

Asian Journal of Chemistry, Vol. 34 No. 6 (2022): Vol 34 Issue 6

Abstract

The novel coronavirus, COVID-19, caused by SARS-CoV-2, is a global health pandemic and currently no specific drug is available to prevent or cure this novel coronavirus (SARS-CoV-2) disease. We have been put forth five pyrimidine ring containing compounds as potential antiviral candidatures for the treatment of COVID-19 diseases based on quantum chemical properties predicted by molecular docking study and DFT calculations at the level of B3LYP method with 6-311++G (d,p) basis set. Our findings were also compared to remdesivir, a control ligand. Blind docking with the main protease revealed that the ligands preferentially bind to the active site. Interestingly, all of the ligands exhibited low binding free energies i.e., strong inhibitory interactions with the active sites of the main protease. Ligand L1 was one of them, which revealed significantly low binding energies (-8.8 kcal/mol) with SARS-CoV-2 Mpro. These binding energies are even lower than those of remdesivir’s potent active metabolite. All of the drugs interact with the key active site residues, including His41 and Cys145. These findings are also strongly supported by quantum chemical investigations.

Keywords

COVID-19 Pyrimidine ring HOMO-LUMO Molecular docking DFT calculations
Helen, S., Liton, M., Das, M., & Nuruzzaman, M. (2022). Study of Antiviral Activity of Some Pyrimidine Ring Containing Compounds against COVID-19 Based on Molecular Docking and Quantum Chemical Calculations by DFT Method. Asian Journal of Chemistry, 34(6), 1517–1525. https://doi.org/10.14233/ajchem.2022.23689
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. D.S. Hui, E. I Azhar, T.A. Madani, F. Ntoumi, R. Kock, G. Ippolito, O. Dar, T.D. Mchugh, Z.A. Memish, C. Drosten, A. Zumla and E. Petersen, Int. J. Infect. Dis., 91, 264 (2020); https://doi.org/10.1016/j.ijid.2020.01.009
  2. A. Sharma, S. Tiwari, M.K. Deb and J.L. Marty, Int. J. Antimicrob. Agents, 56, 106054 (2020); https://doi.org/10.1016/j.ijantimicag.2020.106054
  3. R.K. Mohapatra, M.M. El-ajaily, F.S. Alassbaly, A.K. Sarangi, D. Das, A.A. Maihub, S.F. Ben-Gweirif, A. Mahal, M. Suleiman, L. Perekhoda, M. Azam and T.H. Al-Noor, Chem. Pap., 75, 1005 (2021); https://doi.org/10.1007/s11696-020-01342-8
  4. R.K. Mohapatra, P.K. Das and V. Kandi, Diabetes Metab. Syndr., 14, 1593 (2020); https://doi.org/10.1016/j.dsx.2020.08.024
  5. J. Liang, C. Karagiannis, E. Pitsillou, K.K. Darmawan, K. Ng, A. Hung and T.C. Karagiannis, Comput. Biol. Chem., 89, 107372 (2020); https://doi.org/10.1016/j.compbiolchem.2020.107372
  6. K. Kapusta, S. Kar, J.T. Collins, L.M. Franklin, W. Kolodziejczyk, J. Leszczynski and G.A. Hill, J. Biomol. Struct. Dyn., 39, 6810 (2021); https://doi.org/10.1080/07391102.2020.1806930
  7. S. Chidambaram, M.A. El-Sheikh, A.H. Alfarhan, S. Radhakrishnan and I. Akbar, Saudi J. Biol. Sci., 28, 1100 (2021); https://doi.org/10.1016/j.sjbs.2020.11.038
  8. I. Achilonu, E.A. Iwuchukwu, O.J. Achilonu, M.A. Fernandes and Y. Sayed, J. Mol. Graph. Model., 101, 107730 (2020); https://doi.org/10.1016/j.jmgm.2020.107730
  9. A. El-Demerdash, A.A. Al-Karmalawy, T.M. Abdel-Aziz, S.S. Elhady, K.M. Darwish and A.H.E. Hassan, RSC Adv., 11, 31339 (2021); https://doi.org/10.1039/D1RA05817G
  10. K.A. Peele, C.P. Durthi, T. Srihansa, S. Krupanidhi, V.S. Ayyagari, D.J. Babu, M. Indira, A.R. Reddy and T.C. Venkateswarulu, Inform. Med. Unlocked, 19, 100345 (2020); https://doi.org/10.1016/j.imu.2020.100345
  11. M. E. Sobhia, G. S. Kumar, S. Sivangula, K. Ghosh, H. Singh, T. Haokip and J. Gibson, Future Med. Chem., 13, 1435 (2021); https://doi.org/10.4155/fmc-2020-0264
  12. Z. Abdelrahman, M. Li and X. Wang, Front. Immunol., 11, 552909 (2020); https://doi.org/10.3389/fimmu.2020.552909
  13. U. Bacha, J. Barrila, A. Velazquez-Campoy, S.A. Leavitt and E. Freire, Biochem., 43, 4906 (2004); https://doi.org/10.1021/bi0361766
  14. F.A.D.M. Opo, M.M. Rahman, F. Ahammad, I. Ahmed, M.A. Bhuiyan and A.M. Asiri, Sci. Rep., 11, 4049 (2021); https://doi.org/10.1038/s41598-021-83626-x
  15. J.L. Araújo, L.A. de Sousa, A.O. Sousa, R.S. Bastos, G.T. Santos, M.R. Lage, S.R. Stoyanov, I.N.G. Passos, R.B. de Azevedo and J.A. Rocha, J. Braz. Chem. Soc., 32, 1628 (2021); https://dx.doi.org/10.21577/0103-5053.20210061
  16. B. Gogoi, P. Chowdhury, N. Goswami, N. Gogoi, T. Naiya, P. Chetia, S. Mahanta, D. Chetia, B. Tanti, P. Borah and P.J. Handique, Mol. Divers., 25, 1963 (2021); https://dx.doi.org/10.1007/s11030-021-10211-9
  17. R. Carrasco-Velar, J.A. Padron and J. Galvez, J. Pharm. Pharm. Sci., 7, 19 (2004).
  18. V.R. Murthy, D.V. Raghuram and P.N. Murthy, Bioinformation, 2, 12 (2007); https://dx.doi.org/10.6026/97320630002012
  19. M.F. Costa, Ciencias exatas e tecnologicas. Londrina, 31, 31 (2010); https://doi.org/10.5433/1679-0375.2010v31n1p31
  20. M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G.A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H.P. Hratchian, A.F. Izmaylov, J. Bloino, G. Zheng, J.L. Sonnenberg, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H.
  21. Nakai, T. Vreven, J.A. Montgomery Jr., J.E. Peralta, F. Ogliaro, M. Bearpark, J.J. Heyd, E. Brothers, K N. Kudin, V.N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J.C. Burant, S.S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J.M. Millam, M. Klene, J.E. Knox, J.B. Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R.E. Stratmann, O. Yazyev, A.J. Austin, R. Cammi, C. Pomelli, J.W. Ochterski, R.L. Martin, K. Morokuma, V.G. Zakrzewski, G.A. Voth, P. Salvador, J.J. Dannenberg, S. Dapprich, A.D. Daniels, Ö. Farkas, J.B. Foresman, J.V. Ortiz, J. Cioslowski and D.J. Fox, Gaussian 09, Revision E.01, Gaussian, Inc., Wallingford CT (2009).
  22. C. Lee, W. Yang and R.G. Parr, Phys. Rev. B Condens. Matter, 37, 785 (1988); https://doi.org/10.1103/PhysRevB.37.785
  23. A.D. Becke, J. Chem. Phys., 98, 5648 (1993); https://doi.org/10.1063/1.464913
  24. H. Vural and I. Uçar, J. Coord. Chem., 69, 3010 (2016); https://doi.org/10.1080/00958972.2016.1225042
  25. S. Azhagiri, S. Jayakumar, S. Gunasekaran and S. Srinivasan, Spectrochim. Acta A Mol. Biomol. Spectrosc., 124, 199 (2014); https://doi.org/10.1016/j.saa.2013.12.106
  26. R. Dennington, T.A. Keith and J.M. Millam, GaussView, Version 6, Semichem Inc., Shawnee Mission, KS ( 2016).
  27. O. Trott and A.J. Olson, J. Comput. Chem., 31, 455 (2010); https://doi.org/10.1002/jcc.21334
  28. W.L. DeLano, The PyMOL Molecular Graphics System, Delano Scientific, San Carlos, USA (2002).
  29. L. Zhang, D. Lin, X. Sun, U. Curth, C. Drosten, L. Sauerhering, S. Becker, K. Rox and R. Hilgenfeld, Sci., 368, 409 (2020); https://doi.org/10.1126/science.abb3405
  30. N. Guex and M.C. Peitsch, Electrophoresis, 18, 2714 (1997); https://doi.org/10.1002/elps.1150181505
  31. T.D. Goddard, C.C. Huang, E.C. Meng, E.F. Pettersen, G.S. Couch, J.H. Morris and T.E. Ferrin, Protein Sci., 27, 14 (2018); https://doi.org/10.1002/pro.3235
  32. M.A. Jordaan, O. Ebenezer, N. Damoyi and M. Shapi, Heliyon, 6, e04642 (2020); https://doi.org/10.1016/j.heliyon.2020.e04642
  33. A. Semeniuk, J. Kalinowska-Tluscik, W. Nitek and B.J. Oleksyn, J. Chem. Crystallogr., 38, 333 (2008); https://doi.org/10.1007/s10870-008-9327-9
  34. E. Eroglu and H. Türkmen, J. Mol. Graph. Model., 26, 701 (2007); https://doi.org/10.1016/j.jmgm.2007.03.015
  35. S. LaPointe and D. Weaver, Curr. Comput. Aided Drug Des., 3, 290 (2007); https://doi.org/10.2174/157340907782799390
  36. A.M. Ferreira, M. Krishnamurthy, B.M. Moore II, D. Finkelstein and D. Bashford, Bioorg. Med. Chem., 17, 2598 (2009); https://doi.org/10.1016/j.bmc.2008.11.059
  37. N.C. Garbett and J.B. Chaires, Expert Opin. Drug Discov., 7, 299 (2012); https://doi.org/10.1517/17460441.2012.666235
  38. G.W. Ejuh, C. Fonkem, Y.T. Assatse, R.A. Yossa Kamsi, T. Nya, L.P. Ndukum, J.M.B. Ndjaka, Heliyon, 6, e04647 (2020); https://doi.org/10.1016/j.heliyon.2020.e04647
  39. R.G. Parr, L.V. Szentpaly and S. Liu, J. Am. Chem. Soc., 121, 1922 (1999); https://doi.org/10.1021/ja983494x
Read More
Author biographies is not available.
Download
PDF
Statistic
Read Counter : 4 Download : 1